On the stock market since 1986, it operates in the world of consumer spending. It has 928 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
An average decline of 7% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
Executives buying with their own money is usually read as confidence in the company’s future.
An investor who bought at the very peak is down 94% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 12 months, company executives reported 17 buys and 13 sells. Management buying with its own money is usually read as a good sign.
It pays out $0.15 per share each year — regular cash for whoever holds the stock.
A loss of $7.6M against $257.4M in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.40. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, DXYN sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: DXYN is a small company that closed last year at a loss. The road back to profit runs through spending discipline.